http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#Head http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#provenance http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#pubinfo http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion http://purl.obolibrary.org/obo/DOID_3908 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_3908 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB09559 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association http://www.w3.org/2000/01/rdf-schema#label portrazza tm is an epidermal growth factor receptor egfr antagonist indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer 1 1 limitation of use portrazza is not indicated for treatment of non squamous non small cell lung cancer 1 2 5 6 14 2 portrazza tm is indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer portrazza is not indicated for treatment of non squamous non small cell lung cancer see warnings and precautions 5 6 14 2 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB09559 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#provenance http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#pubinfo http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig http://purl.org/nanopub/x/hasSignature JQ3ur+2NrejCz4bLGmSGWxqqKT0y5vUUFvLIRmq8+kKGN7G67AG1JFNBzi8Tk4DpVcQJ4VbuaxY4dZR75Ir8I9HqKTSGB831XYcrRNuuwD17SVa/DXVYx3zp+A4CF449OpkxLiusyIRz3VMy2HB7dH6dVZDo86mkWsNbE1qhBNc= http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://purl.org/dc/terms/created 2021-06-12T12:49:14.696+02:00 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAy7Q0nPrAHRtqLlmaN7K9RGiXDE95II4Mhtv2zNfmC2c https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs